To determine the performance of MRI for detecting clinically significant prostate cancer (csPCa) recurrence following focal cryo-ablation over five years of oncological surveillance. A total of 305 ...

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational ...

High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

With focal therapy, doctors are now able to destroy cancer cells without damaging the surrounding nerves and tissue. In today’s Healthcast, Local 10’s Kristi Krueger talked to the first man in Broward ...

PAR Technology now trades at a reset valuation near 4x revenue, presenting an attractive entry after operational noise earlier this year. Q3 results showed 22% ARR growth to $298M, 25% subscription ...

Francis Medical is heating up with a 510(k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of the prostate, kidneys and bladder. The regulatory go-ahead for its Vanquish ...

Francis Medical recently won FDA 510(k) clearance for its Vanquish Water Vapor Ablation System, a new device for minimally invasive prostate ablation. The Vanquish system uses water vapor for focal ...